A federal deadline in December could reshape a Pennsylvania hemp market that operators estimate generates roughly a billion dollars a year, and Lancaster County is a useful place to watch the fallout. Congress recently closed a loophole that had allowed hemp-derived products containing trace amounts of Delta-9 THC to be sold largely outside the regulatory structure that governs adult-use and medical cannabis. Now lawmakers in Washington are weighing tighter restrictions, or an outright ban, on the very category that businesses like Endo, founded by Jake Sitler, were built around.
Sitler, who also serves as president of the Pennsylvania Hemp and Cannabis Guild, sells CBD-forward beverages, gummies and topicals that also contain Delta-9 THC and other minor cannabinoids. That combination is precisely what regulators are scrutinizing. Unlike state-licensed dispensaries, which operate under seed-to-sale tracking, mandatory lab testing and point-of-sale systems built for compliance reporting - the kind of infrastructure discussed on platforms like dispensary pos washington operators already use daily - many hemp retailers have functioned with far less oversight. That gap is exactly what's drawing attention from Harrisburg and Capitol Hill alike.
Why the Loophole Became a Liability
The 2018 Farm Bill legalized hemp and hemp-derived products with less than 0.3% Delta-9 THC by dry weight, a threshold that sounds tidy on paper but, in practice, left room for manufacturers to infuse beverages and edibles with intoxicating amounts of THC while technically staying under the legal limit. No purchase-age mandate, no statewide potency cap, no uniform lab-testing standard comparable to what licensed cannabis operators must meet through a certificate of analysis. Pennsylvania Attorney General Dave Sunday has pointed to that exact gap - companies producing THC-infused products without the regulatory scaffolding that governs the state's medical cannabis program.
Sitler doesn't dispute that concern. He's posted 21-and-older signage in his stores voluntarily and says he supports regulation rather than opposes it. But he draws a sharp line between operators building compliant, tested products and what he calls the "bad side" of the industry - unregulated sellers whose products likely fueled the political pressure now threatening the entire category, including hemp farming itself.
What a Ban Would Mean for Retailers and Farmers
A blanket ban wouldn't just shutter storefronts. It would ripple through wholesale menus, hemp cultivation contracts, extraction facilities and the small-business finance arrangements many hemp companies rely on since they've avoided the 280E tax burdens that licensed cannabis operators absorb. Farmers who shifted acreage toward hemp under the Farm Bill's promise of a legal crop now face the prospect of that market disappearing entirely, not through market forces but through statute.
- Loss of a legal outlet for hemp biomass currently grown under Farm Bill provisions
- Disruption of wholesale and retail supply chains built around CBD and low-dose THC products
- Uncertainty for compliant operators who invested in testing, packaging and age-verification protocols
- Pressure on state lawmakers to build a licensing and testing framework before Washington acts unilaterally
Sitler's advocacy through the Pennsylvania Hemp and Cannabis Guild centers on a middle path: real regulation - potency limits, testing requirements, purchase-age enforcement - without eliminating the agricultural and retail base that's grown up around hemp since 2018. Whether Congress or Harrisburg lands there before December is, at this point, an open question with real consequences for compliant business owners and farmers who've operated in good faith under existing law.
